Enoxaparin sodium for injection
Generic name:Enoxaparin Sodium for Injection
Active ingredients:Enoxaparin Sodium
Excipient:Mannitol
Description:A white porous mass.
Indications
1.Preventionof venous thromboembolic diseases (prevention of intravenous thrombosis), especially for thrombosis associated with orthopedic or general surgery.
2.Treatment for deep venous thrombosiswith or without pulmonary embolism.Clinical symptoms are not serious and does not include pulmonary embolism requiring surgery or thrombolytic therapy.
3.Treatment for unstable angina and non-Q-wave myocardial infarctionwhen combined with aspirin.
4.Prevention of thrombogenesisin hemodialysis extracorporeal circulation.
Strength
4000AxaIU
Dosage and administration
When administrated for the prevention of venous thromboembolic disease, treatment of deep vein thrombosis, treatment of unstable angina and non-Q-wave myocardial infarction, the subcutaneous injection is applied. When administrated for hemodialysis extracorporeal circulation, the intravascular administration is applied.
This medicine is only used for adults.
Intramuscular injection is prohibited.
Before use, add 0.4ml of normal saline or water for injection into 1 vial fordissolvingthe content completely to obtain aninjection solution having 10000AxaIU per ml, equivalent to 100mg Enoxaparin sodium. Each mg (0.01 ml) of Enoxaparin sodium is approximately equal to 100 AxaIU.
Packaging size
2 vials/box
Approval number
GUOYAOZHUNZI H20150010
Active ingredients:Enoxaparin Sodium
Excipient:Mannitol
Description:A white porous mass.
Indications
1.Preventionof venous thromboembolic diseases (prevention of intravenous thrombosis), especially for thrombosis associated with orthopedic or general surgery.
2.Treatment for deep venous thrombosiswith or without pulmonary embolism.Clinical symptoms are not serious and does not include pulmonary embolism requiring surgery or thrombolytic therapy.
3.Treatment for unstable angina and non-Q-wave myocardial infarctionwhen combined with aspirin.
4.Prevention of thrombogenesisin hemodialysis extracorporeal circulation.
Strength
4000AxaIU
Dosage and administration
When administrated for the prevention of venous thromboembolic disease, treatment of deep vein thrombosis, treatment of unstable angina and non-Q-wave myocardial infarction, the subcutaneous injection is applied. When administrated for hemodialysis extracorporeal circulation, the intravascular administration is applied.
This medicine is only used for adults.
Intramuscular injection is prohibited.
Before use, add 0.4ml of normal saline or water for injection into 1 vial fordissolvingthe content completely to obtain aninjection solution having 10000AxaIU per ml, equivalent to 100mg Enoxaparin sodium. Each mg (0.01 ml) of Enoxaparin sodium is approximately equal to 100 AxaIU.
Packaging size
2 vials/box
Approval number
GUOYAOZHUNZI H20150010
